Enrique Poradosu

2022

In 2022, Enrique Poradosu earned a total compensation of $970.3K as Chief Scientific & Business Officer at Nuvectis Pharma.

Compensation breakdown

Bonus$200,000
Salary$349,072
Stock Awards$421,200
Total$970,272

Poradosu received $421.2K in stock awards, accounting for 43% of the total pay in 2022.

Poradosu also received $200K in bonus and $349.1K in salary.

Rankings

In 2022, Enrique Poradosu's compensation ranked 3,087th out of 5,736 executives tracked by ExecPay. In other words, Poradosu earned more than 46.2% of executives.

ClassificationRankingPercentile
All
3,087
out of 5,736
46th
Division
Manufacturing
1,736
out of 3,125
44th
Major group
Chemicals And Allied Products
819
out of 1,416
42nd
Industry group
Drugs
765
out of 1,317
42nd
Industry
Pharmaceutical Preparations
555
out of 963
42nd
Source: SEC filing on April 29, 2024.

Poradosu's colleagues

We found two more compensation records of executives who worked with Enrique Poradosu at Nuvectis Pharma in 2022.

2022

Ron Bentsur

Nuvectis Pharma

Chief Executive Officer

2022

Shay Shemesh

Nuvectis Pharma

Chief Development & Operations Officer

News

You may also like